Hanwha Life Buy Rating Kept as Kiwoom Cites Strong Investment Gains

Kiwoom Securities said on the 13th that it maintained its Buy rating and 8,500 won target price for Hanwha Life. The brokerage said insurance profit is expected to decline, while investment income remains favorable. The view reflects first-quarter conditions in which weaker insurance earnings were identified, but investment gains helped support the overall recovery picture. Kiwoom Securities said the strength in investment income could back Hanwha Life’s gradual improvement despite softer insurance profit. Based on the provided source text, the exact first-quarter net profit figure was not disclosed. Source: mk.co.kr